Terms: = Endocrine gland cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
41 results:
1. hsa_circ_0007919 induces LIG1 transcription by binding to foxa1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Xu L; Ma X; Zhang X; Zhang C; Zhang Y; Gong S; Wu N; Zhang P; Feng X; Guo J; Zhao M; Ren Z; Zhang P
Mol Cancer; 2023 Dec; 22(1):195. PubMed ID: 38044421
[TBL] [Abstract] [Full Text] [Related]
2. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Ferguson LP; Gatchalian J; McDermott ML; Nakamura M; Chambers K; Rajbhandari N; Lytle NK; Rosenthal SB; Hamilton M; Albini S; Wartenberg M; Zlobec I; Galván JA; Karamitopoulou E; Vavinskaya V; Wascher A; Lowy AM; Schürch CM; Puri PL; Bruneau BG; Hargreaves DC; Reya T
Nat Commun; 2023 Jan; 14(1):292. PubMed ID: 36653361
[TBL] [Abstract] [Full Text] [Related]
3. Systematic Pan-cancer Analysis and Experimental Verification Identify foxa1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian cancer.
Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical evaluation of forkhead box A1 and EphA5 markers in serous ovarian carcinomas, and their impact on the clinical outcome of patients.
Abouhashem N; Harb O; Elwan A; Zaitoun M; Saraya Y
Pol J Pathol; 2022; 73(2):120-133. PubMed ID: 36345952
[TBL] [Abstract] [Full Text] [Related]
5. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.
Gershenson DM; Cobb LP; Westin SN; Zhang Y; Jazaeri A; Malpica A; Sun CC
Gynecol Oncol; 2022 Nov; 167(2):139-145. PubMed ID: 36137845
[TBL] [Abstract] [Full Text] [Related]
6. Serum Autoantibodies against LRDD, STC1, and foxa1 as Biomarkers in the Detection of Ovarian cancer.
Duan Y; Cui C; Qiu C; Sun G; Wang X; Wang P; Ye H; Dai L; Shi J
Dis Markers; 2022; 2022():6657820. PubMed ID: 35273656
[TBL] [Abstract] [Full Text] [Related]
7. foxa1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma.
Lou T; Liu C; Qu H; Zhang Z; Wang S; Zhuang H
J Transl Med; 2022 Jan; 20(1):19. PubMed ID: 34991620
[TBL] [Abstract] [Full Text] [Related]
8. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
Li Y; Jaiswal SK; Kaur R; Alsaadi D; Liang X; Drews F; DeLoia JA; Krivak T; Petrykowska HM; Gotea V; Welch L; Elnitski L
BMC Cancer; 2021 Jul; 21(1):768. PubMed ID: 34215221
[TBL] [Abstract] [Full Text] [Related]
9. High foxa1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.
Sheta H; Abd El Hafez A; Saif M; Elsergany AR; Al Emam D; Abdelrazik MM
Pathologica; 2021 Apr; 113(2):102-114. PubMed ID: 34042091
[TBL] [Abstract] [Full Text] [Related]
10. Oncogenic
Kim MP; Li X; Deng J; Zhang Y; Dai B; Allton KL; Hughes TG; Siangco C; Augustine JJ; Kang Y; McDaniel JM; Xiong S; Koay EJ; McAllister F; Bristow CA; Heffernan TP; Maitra A; Liu B; Barton MC; Wasylishen AR; Fleming JB; Lozano G
Cancer Discov; 2021 Aug; 11(8):2094-2111. PubMed ID: 33839689
[TBL] [Abstract] [Full Text] [Related]
11. foxa1 Expression by Immunohistochemistry in Carcinosarcomas of the Endometrium and Ovary/Fallopian Tube.
Karpathiou G; Chauleur C; Dal Col P; Peoc'h M
Int J Gynecol Pathol; 2021 Nov; 40(6):611-616. PubMed ID: 33770058
[TBL] [Abstract] [Full Text] [Related]
12. Effect of centralization and regionalization of pancreatic surgery on resection rates and survival.
Latenstein AEJ; Mackay TM; van der Geest LGM; van Eijck CHJ; de Meijer VE; Stommel MWJ; Vissers PAJ; Besselink MG; de Hingh IHJT;
Br J Surg; 2021 Jul; 108(7):826-833. PubMed ID: 33738473
[TBL] [Abstract] [Full Text] [Related]
13. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating foxa1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract] [Full Text] [Related]
14. TET2 directs mammary luminal cell differentiation and endocrine response.
Kim MR; Wu MJ; Zhang Y; Yang JY; Chang CJ
Nat Commun; 2020 Sep; 11(1):4642. PubMed ID: 32934200
[TBL] [Abstract] [Full Text] [Related]
15. Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms.
Huang B; Trujillo MA; Fujikura K; Qiu M; Chen F; Felsenstein M; Zhou C; Skaro M; Gauthier C; Macgregor-Das A; Hutchings D; Hong SM; Hruban RH; Eshleman JR; Thompson ED; Klein AP; Goggins M; Wood LD; Roberts NJ
J Pathol; 2020 Nov; 252(3):252-262. PubMed ID: 32696980
[TBL] [Abstract] [Full Text] [Related]
16. Signification of forkhead box A1 (foxa1) expression in thyroid cancers.
Missaoui N; Chouaibi S; Limam S; Mhamdi N; Zahmoul T; Hamchi H; Mokni M; Hmissa S
J Egypt Natl Canc Inst; 2019 Dec; 31(1):11. PubMed ID: 32372175
[TBL] [Abstract] [Full Text] [Related]
17. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract] [Full Text] [Related]
18. BACH1 Promotes Pancreatic cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
[TBL] [Abstract] [Full Text] [Related]
19. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner.
Milan M; Balestrieri C; Alfarano G; Polletti S; Prosperini E; Spaggiari P; Zerbi A; Diaferia GR; Natoli G
EMBO J; 2019 Oct; 38(20):e102161. PubMed ID: 31531882
[TBL] [Abstract] [Full Text] [Related]
20. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
[TBL] [Abstract] [Full Text] [Related]
[Next]
